<?xml version="1.0" encoding="UTF-8"?>
<document id="28346420">
	<sentence id="s1" text="Cyclooxygenase (COX)-2 is upregulated in hepatocellular carcinoma (HCC).">
		<entity id="s1.e1" charOffset="16-19"
			type="GENE" text="COX" ontology_id="1351"/>
		<entity id="s1.e2" charOffset="41-65"
			type="HP" text="hepatocellular carcinoma" ontology_id="HP_0001402"/>
		<entity id="s1.e3" charOffset="67-70"
			type="GENE" text="HCC" ontology_id="84668"/>
		<pair id="s1.p1" e1="s1.e1"
		    e2="s1.e2" pgr="false"/>
		<pair id="s1.p2" e1="s1.e2"
		    e2="s1.e3" pgr="false"/>
	</sentence>
	<sentence id="s2" text="Reduced representation bisulfite sequencing (RRBS) and gene expression microarrays were performed in the HCC tumor and non-HCC liver tissues to investigate the molecular mechanisms of COX-2-driven HCC.">
		<entity id="s2.e1" charOffset="105-108"
			type="GENE" text="HCC" ontology_id="84668"/>
		<entity id="s2.e2" charOffset="109-114"
			type="HP" text="tumor" ontology_id="HP_0002664"/>
		<entity id="s2.e3" charOffset="184-187"
			type="GENE" text="COX" ontology_id="1351"/>
		<pair id="s2.p1" e1="s2.e3"
		    e2="s2.e3" pgr="false"/>
		<pair id="s2.p2" e1="s2.e1"
		    e2="s2.e2" pgr="false"/>
	</sentence>
	<sentence id="s3" text="Bio-functional investigation revealed that LTBP1 inhibited cell proliferation in HCC cell lines, suggesting its potential role as a tumor suppressor in HCC.">
		<entity id="s3.e1" charOffset="43-48"
			type="GENE" text="LTBP1" ontology_id="4052"/>
		<entity id="s3.e2" charOffset="81-84"
			type="GENE" text="HCC" ontology_id="84668"/>
		<entity id="s3.e3" charOffset="132-137"
			type="HP" text="tumor" ontology_id="HP_0002664"/>
		<pair id="s3.p1" e1="s3.e3"
		    e2="s3.e3" pgr="false"/>
		<pair id="s3.p2" e1="s3.e1"
		    e2="s3.e3" pgr="false"/>
	</sentence>
	<sentence id="s4" text="In conclusion, this study demonstrated for the first time that enhanced COX-2 expression in hepatocytes is sufficient to induce HCC through inducing promoter hypermethylation by reducing TET1, silencing tumor-suppressive genes and activating key oncogenic pathways.">
		<entity id="s4.e1" charOffset="72-75"
			type="GENE" text="COX" ontology_id="1351"/>
		<entity id="s4.e2" charOffset="128-131"
			type="GENE" text="HCC" ontology_id="84668"/>
		<entity id="s4.e3" charOffset="187-191"
			type="GENE" text="TET1" ontology_id="80312"/>
		<entity id="s4.e4" charOffset="203-208"
			type="HP" text="tumor" ontology_id="HP_0002664"/>
		<pair id="s4.p1" e1="s4.e1"
		    e2="s4.e4" pgr="false"/>
		<pair id="s4.p2" e1="s4.e2"
		    e2="s4.e4" pgr="false"/>
		<pair id="s4.p3" e1="s4.e3"
		    e2="s4.e4" pgr="false"/>
	</sentence>
</document>
